Skip to main content
Top
Published in: European Journal of Pediatrics 10/2017

Open Access 01-10-2017 | Case Report

Pneumococcal meningitis and endocarditis in an infant: possible improved survival with factor V Leiden mutation

Authors: Sitikant Mohapatra, Assaf Doulah, Elspeth Brown

Published in: European Journal of Pediatrics | Issue 10/2017

Login to get access

Abstract

Streptococcus pneumoniae infections continue to remain associated with high morbidity and mortality. Although the incidence of invasive meningeal and/or lung disease are not uncommon, Streptococcus pneumoniae endocarditis is rare especially in healthy pediatric population. New studies have suggested a strong association between factor V leiden (FVL) mutation and favorable outcomes in critically ill children. A healthy 10 month old presented with sepsis and meningeal signs, was later confirmed to have Streptococcus pneumoniae meningitis and endocarditis. She was found to have factor V leiden mutation and made a complete recovery despite initial complications.
Conclusion: Presence of factor V leiden mutation in critically ill children with severe septicaemia possibly contributes to better outcomes.
What is known:
• Mortality and morbidity remain high with invasive pneumococcal disease.
• Pneumococcal endocarditis is rare in healthy pediatric population and results in significant morbidity and mortality
What is new:
• New studies have suggested a strong association between factor V leiden (FVL) mutation and favorable outcomes in critically ill children.
• The presence of factor V mutation in children with extensive invasive pneumococcal disease possibly contributes to a better outcome.
Literature
1.
go back to reference Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, Wilson W, Bolger AF, Bayer A, Levison ME, Pallasch TJ, Gage TW, Taubert KA; Unique features of infective endocarditis in childhood, Pediatrics 2002;109(5):931–943 Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, Wilson W, Bolger AF, Bayer A, Levison ME, Pallasch TJ, Gage TW, Taubert KA; Unique features of infective endocarditis in childhood, Pediatrics 2002;109(5):931–943
2.
go back to reference Givner LB, Mason EO Jr, Tan TQ, Barson WJ, Schutze GE, Wald ER, Bradley JS, Hoffman J, Yogev R, Kaplan SL (2004) Pneumococcal endocarditis in children. Clin Infect Dis 38(9):1273–1278 Epub 2004 Apr 14CrossRefPubMed Givner LB, Mason EO Jr, Tan TQ, Barson WJ, Schutze GE, Wald ER, Bradley JS, Hoffman J, Yogev R, Kaplan SL (2004) Pneumococcal endocarditis in children. Clin Infect Dis 38(9):1273–1278 Epub 2004 Apr 14CrossRefPubMed
3.
go back to reference Cramer TJ, Gale AJ (2012) The anticoagulant function of coagulation factor V. Thromb Haemost 107:15–21CrossRefPubMed Cramer TJ, Gale AJ (2012) The anticoagulant function of coagulation factor V. Thromb Haemost 107:15–21CrossRefPubMed
4.
5.
go back to reference Choi M, Mailman TL (2004) Pneumococcal endocarditis in infants and children. Pediatr Infect Dis J 23(2):166–171CrossRefPubMed Choi M, Mailman TL (2004) Pneumococcal endocarditis in infants and children. Pediatr Infect Dis J 23(2):166–171CrossRefPubMed
6.
go back to reference Kerlin BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR, Joyce DE, Weiler H, Dhainaut JF (2003) Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 102:3085–3092CrossRefPubMed Kerlin BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR, Joyce DE, Weiler H, Dhainaut JF (2003) Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 102:3085–3092CrossRefPubMed
7.
go back to reference Hofstra JJ, Schouten M, Levi M (2007) Thrombophilia and outcome in severe infection and sepsis. Semin Thromb Hemost 33(6):604–609CrossRefPubMed Hofstra JJ, Schouten M, Levi M (2007) Thrombophilia and outcome in severe infection and sepsis. Semin Thromb Hemost 33(6):604–609CrossRefPubMed
8.
go back to reference Kerschen E, Hernandez I, Zogg M, Maas M, Weiler H (2015) Survival advantage of heterozygous factor V Leiden carriers in murine sepsis. J Thromb Haemost 13:1073–1080CrossRefPubMedPubMedCentral Kerschen E, Hernandez I, Zogg M, Maas M, Weiler H (2015) Survival advantage of heterozygous factor V Leiden carriers in murine sepsis. J Thromb Haemost 13:1073–1080CrossRefPubMedPubMedCentral
9.
go back to reference Yan SB, Nelson DR (2004) Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C. Crit Care Med 32(5 Suppl):S239–S246CrossRefPubMed Yan SB, Nelson DR (2004) Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C. Crit Care Med 32(5 Suppl):S239–S246CrossRefPubMed
Metadata
Title
Pneumococcal meningitis and endocarditis in an infant: possible improved survival with factor V Leiden mutation
Authors
Sitikant Mohapatra
Assaf Doulah
Elspeth Brown
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 10/2017
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-017-2973-1

Other articles of this Issue 10/2017

European Journal of Pediatrics 10/2017 Go to the issue